Cancer is not what it used to be, and there are now significant improvements in cancer screening and treatment for patients. In the past 30 years alone, the number of cancer survivors has increased to15.5 million, and the number is set to increase to 26.1 million by the year 2040. Out of the current 15.5 million cancer survivors, 50% lived for 10 years after they were diagnosed. Two-thirds of these survivors have lived past five years. 80% of lung cancer survivors are excluded from the National Cancer Institute’s clinical trials. What this means is that 25% of patients who have prior cancer diagnoses are excluded from these trials.
The research studied patients who were newly diagnosed with cancer between the beginning of 2009 and the end of December 2013 and came up with the results described above. These patients were sourced from the National Cancer Institute’s registry. It is important to consider patients who have had cancer previously and conduct research on them because the delivery of care towards such patients is different. Treatment for the newly diagnosed disease may affect the treatment and management of previous disease. The study concludes that it is important for clinical trials to include prior cancer patients in order to avoid generalizing results and also improving the patient experience.
Eric Lefkofsky co-founded and is the CEO of Tempus, a company that is finding new and different ways to morph technology into the medical industry. One of these ways is by building a library of clinical data that will go a long way in offering patients customized healthcare because healthcare providers will be armed with more useful information from those who came before them.
Aside from his role at Tempus, Eric has founded various other companies and is a professor at the University of Chicago. He is also keen on giving back to the community and founded the Lefkofsky Family Foundation along with his wife. They offer support to The Art Institute of Chicago, World Business Chicago, and Lurie Children’s hospital. Their impact and dedication to better healthcare is admirable and will impact generations.
To Learn More Click Here